Mayo Clinic Florida
Amprion Partners With Mayo Clinic to Evaluate Biomarker Test in Rapidly Progressive Dementia
Amprion's test was launched in late 2021 and is designed to detect alpha-synuclein aggregates, a hallmark of various brain diseases.
The 32-gene signature showed potential in predicting South Korean gastric cancer patients' overall survival and response to chemotherapy and immunotherapy.
At the AACR annual meeting, researchers shared detection rate data for multi-cancer screening tests from Grail and Thrive Earlier Detection.
New Studies Link Rare Variant to Alzheimer's Disease Risk
NEW YORK (GenomeWeb News) – A pair of studies that appeared in The New England Journal of Medicine this week identified a rare variant of the TREM2 gene as a potent risk factor for late-onset Alzheimer's disease.